Patent · US Active

Antibody molecules and conjugates

US12065496B2 · kind B2 · utility

0Cited by

0References

27Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Frank COMER · Gaithersburg, US
Yariv Mazor · Austin, US
Srinath Kasturirangan · Gaithersburg, US
Qun Du · Gaithersburg, US
Chunning YANG · Gaithersburg, US
Andrew Buchanan · Cambridge, GB

Key dates

Filing date	Nov 9, 2022
Grant date	Aug 20, 2024
Priority date	—
Expiry date	Nov 9, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to antibody molecules that bind epidermal growth factor receptor (EGFR) and/or c-Met and conjugates containing these antibody molecules. The antibody molecules and conjugates find application in the treatment of cancer, for example.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.